The multimillion-dollar facility combines discovery and early-phase scale-up capabilities with R&D labs and two pilot plants
The partnership aims to develop a first-in-class broad-spectrum antifungal to combat life-threatening invasive infections
The partnership builds on a prior collaboration between Nimbus and Lilly targeting AMPK in cardiometabolic diseases
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
Under the agreement, Insilico could receive up to $32 million in upfront and near-term R&D payments
Ushio, a leader in advanced optical technologies, brings a strong track record and proprietary Photobonding technology
Under the terms of the deal, AstraZeneca gains exclusive rights to JAB-23E73 outside of mainland China
Shonan iPark was chosen for its globally connected life-science ecosystem, which unites pharmaceutical firms, next-generation medicine developers, AI and digital health innovators, venture capital, and academia
The move strengthens GBL’s clinical-stage presence in the United States
The randomized, double-blind, placebo-controlled single ascending dose (SAD) study evaluated safety, tolerability, pharmacokinetics, and target engagement in 46 healthy participants
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
